LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer

Triple negative breast cancer (TNBC) is an aggressive type of breast cancer with high heterogeneity. To date, there is no efficient therapy for TNBC patients and the prognosis is poor. It is urgent to find new biomarkers for the diagnosis of TNBC or efficient therapy targets. As an area of focus in...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Lv, Mingming, Xu, Pengfei, Wu, Ying, Huang, Lei, Li, Wenqu, Lv, Shanshan, Wu, Xiaowei, Zeng, Xin, Shen, Rong, Jia, Xuemei, Yin, Yongmei, Gu, Yun, Yuan, Hongyan, Xie, Hui, Fu, Ziyi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2016
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4914340/
https://ncbi.nlm.nih.gov/pubmed/26910840
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7509
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia